The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 20, 2026

Filed:

Sep. 17, 2021
Applicant:

Nanjing Heron Pharmaceutical Science and Technology Co., Ltd., Nanjing, CN;

Inventors:

Tao Min, Nanjing, CN;

Wenliang Zhou, Nanjing, CN;

Jialin Wang, Nanjing, CN;

Hai Ye, Nanjing, CN;

Ying Xu, Nanjing, CN;

Meiling Mo, Nanjing, CN;

Si Li, Nanjing, CN;

Ye Xu, Nanjing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/407 (2006.01); A61K 9/00 (2006.01); A61K 9/19 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01);
U.S. Cl.
CPC ...
A61K 31/407 (2013.01); A61K 9/0019 (2013.01); A61K 9/19 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01);
Abstract

Provided are a pharmaceutical composition of (S)-ketorolac and a preparation method therefor, which belong to the technical field of pharmaceutical preparations. The pharmaceutical composition includes (S)-ketorolac or a pharmaceutically acceptable salt thereof, a stabilizer, a pH-adjusting agent, and an excipient, and the dosage form of the pharmaceutical composition is preferably lyophilized powder injection. The lyophilized powder injection prepared herein has optical purity of an active ingredient greater than or equal to 95% after being stored under long-term stability test conditions for 6 months and optical purity of an active ingredient greater than or equal to 90% after being stored under accelerated stability test conditions for 6 months. The lyophilized powder injection has important use in the preparation of non-steroidal anti-inflammatory drugs with analgesic, anti-inflammatory, antipyretic effects.


Find Patent Forward Citations

Quick Actions:

Min, Tao. (2026). Pharmaceutical composition of (s)-ketorolac and preparation method therefor (U.S. Patent No. 12766130). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12766130

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…